// App-Quantinova.ai

4682 : Reversal of cisplatin resistance in human ovarian cancer through autophagy inhibition and caspase 1- activation: Role of tumor associated Vacuolar-ATPase

Researchers

Presenter

  • Arpita Kulshrestha

Principal Investigators

  • Gajendra K. Katara

  • Sahithi Pamarthy

  • Alice Gilman-Sachs

  • Kenneth D. Beaman

Medical Centers

  • Rosalind Franklin University of Medicine and Science, North Chicago, IL

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Ovarian cancer

  • Gynaecological cancer

  • Solid malignancies

Biomarkers

  • Cluster of Differentiation 40

  • Cluster of differentiation 95

  • Estrogen Receptor 1

  • Insulin-like growth factor 1 receptor

  • TNF Receptor Superfamily Member 1A

  • Tumor necrosis factor

Drug/Treatment

  • Cisplatin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved